RxDoctor Payments Data

Eunbit Ruppert, NP

Acute Care · Asheville, NCNPI 1821764077

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,977 of the $3,892 with a category attached, or 76.5%. 13 manufacturers reported payments, led by Impulse Dynamics (USA) Inc. at 46.1% of the total. 2025 is the largest year on record at $2,874, more than ten times the $188 reported in 2023. Among acute care clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,892in general payments, 2019–2025

Across 56 payments — averaging $69.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$2K
  • Boston Scientific$528
  • Medtronic$510
  • Abbott$315
  • Biotronik Inc.$239
  • Pfizer$194
  • plus $312 from 7 others

What the payments were for

  • Travel & lodging$91524%
  • Food & beverage$2,97776%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,892 in reported general payments places this provider in the 90th percentile of 312 acute care providers in North Carolina.

See all acute care providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,244
Medicare patients
307
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$85,115
XareltoRivaroxaban31$24,282
MultaqDronedarone Hcl20$18,298
Dofetilide74$8,042
Flecainide Acetate33$1,574
Amiodarone Hcl110$1,174
Metoprolol Succinate49$649
SotalolSotalol Hcl35$311
Pantoprazole Sodium39$250
Colchicine13$240
Carvedilol32$226
Spironolactone19$124
Metoprolol Tartrate32$122
Bumetanide11$95
Propranolol Hcl15$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$194$85,115125 claims
Johnson & JohnsonXarelto$56$24,28231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 312 acute care providers in North Carolina.

Other acute care in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →